Koers Baxter International Inc. London S.E.
Aandelen
0QK8
US0718131099
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
36,35 USD | +7,32% | +7,58% | -6,44% |
Omzet 2024 * | 15,11 mld. 14 mld. | Omzet 2025 * | 15,66 mld. 14,51 mld. | Marktkapitalisatie | 16,9 mld. 15,65 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 703 mln. 651 mln. | Nettowinst (verlies) 2025 * | 950 mln. 880 mln. | EV/omzet 2024 * | 1,77 x |
Nettoschuld 2024 * | 9,85 mld. 9,12 mld. | Nettoschuld 2025 * | 9,06 mld. 8,39 mld. | EV/omzet 2025 * | 1,66 x |
K/w-verhouding 2024 * |
18
x | K/w-verhouding 2025 * |
14,8
x | Werknemers | 60.000 |
Dividendrendement 2024 * |
3,6% | Dividendrendement 2025 * |
3,74% | Vrij verhandelbaar | 74,27% |
Recentste transcriptie over Baxter International Inc.
1 dag | +7,32% | ||
1 week | +7,58% | ||
Lopende maand | +7,58% | ||
1 maand | +0,86% | ||
3 maanden | -17,08% | ||
6 maanden | +0,58% | ||
Lopend jaar | -6,44% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 01-10-15 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 18-10-23 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 06-02-17 |
Peter Wilver
BRD | Director/Board Member | 64 | 10-05-22 |
Director/Board Member | 64 | 18-02-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
07-06-24 | 33,08 | -1,27% | 3 585 |
06-06-24 | 33,5 | +1,45% | 1 294 |
05-06-24 | 33,02 | -1,40% | 1 747 |
04-06-24 | 33,49 | -2,22% | 571 |
03-06-24 | 34,25 | +1,36% | 903 |
uitgestelde koers London S.E., 12 december 2023 om 16:52 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,26% | 187 mld. | |
+2,05% | 110 mld. | |
-1,31% | 69,54 mld. | |
+14,65% | 46,37 mld. | |
-6,69% | 46,05 mld. | |
+7,97% | 42,54 mld. | |
+18,60% | 30,72 mld. | |
-6,87% | 23,32 mld. | |
-10,63% | 22,92 mld. |